Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company commercializes over 500 kinds of Chinese herbal pieces and over 60 refined pieces, focusing on innovative ready-to-use TCM products like Directly-Oral and After-Soaking-Oral forms, and holds national patents for modernized Chinese herbal processing techniques[3][5]. Its pipeline consists of new TCM herbal pieces and formulations entering the Chinese market, supported by strong R&D and regulatory approvals for modern Chinese medicine production. Clinical results are not disclosed in the Western regulatory sense since activity is inferred from traditional historical use and local Chinese clinical evaluations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taizhou Suxuantang Pharmaceutical.